Article(id=1330184200168256117, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184065543680481, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.05.021, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1659974400000, receivedDateStr=2022-08-09, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070226946, onlineDateStr=2026-11-19, pubDate=1683648000000, pubDateStr=2023-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070226946, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070226946, creator=13701087609, updateTime=1795070226946, updator=13701087609, issue=Issue{id=1330184065543680481, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='5', pageStart='635', pageEnd='811', issueExtLink='null', onlineDate='null', pubDate='1683648000000', pubDateStr='2023-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070194849, creator='13701087609', updateTime=1795080478493, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330227198797132113, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184065543680481, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330227198797132114, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184065543680481, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=791, endPage=796, ext={EN=ArticleExt(id=1330184200419914358, articleId=1330184200168256117, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Opinions on Regulatory Requirements and Pharmaceutical Research of Polymorphic Drugs, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Xiaohong XU, Fei LI, Liu YANG, Yongai SI, Qing GONG*, authorsList=Xiaohong XU, Fei LI, Liu YANG, Yongai SI, Qing GONG, authorCompany=null, correspAuthors=Qing GONG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330184201225220727, articleId=1330184200168256117, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=多晶型药物的监管要求及其药学研究思考, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

药物晶型是影响药物疗效的重要因素,关系到药物的安全性、有效性和质量可控性。近年来,药物晶型研究已成为国内外研究的热点。该研究结合国内外药品监管机构的指导原则、技术要求以及当前国内审评技术要求,分析药物晶型研究的关注点、表征方法及典型案例,旨在为多晶型药物的开发和仿制药注册申报提供参考。

, authors=徐晓宏, 李飞, 杨柳, 司咏霭, 龚青*, authorsList=徐晓宏, 李飞, 杨柳, 司咏霭, 龚青, authorCompany=null, correspAuthors=龚青, authorNote=

徐晓宏(1980—),女,工程师,从事化学药物审评研究。

, correspAuthorsNote=
龚青(1983—),男,主任药师,从事化学药物审评研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=n1c3BOUYDyufow26FWW9PA==, magXml=LUwH+MlNcYy40pvM3D6CnA==, pdfUrl=null, pdf=4PDfSFYmYQge4BddDFue8Q==, pdfFileSize=2042061, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=exh6I98rEz6Y9/uB+NmBsg==, mapNumber=null, fund=null)}, authors=[Author(id=1330184203255263868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184203334955646, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203255263868, language=EN, stringName=Xiaohong XU, firstName=Xiaohong, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184203397870207, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203255263868, language=CN, stringName=徐晓宏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

徐晓宏(1980—),女,工程师,从事化学药物审评研究。

"}, bioImg=null, bioContent=

徐晓宏(1980—),女,工程师,从事化学药物审评研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330184203464979073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184203544670851, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203464979073, language=EN, stringName=Fei LI, firstName=Fei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184203670499972, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203464979073, language=CN, stringName=李飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330184203750191750, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184203817300616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203750191750, language=EN, stringName=Liu YANG, firstName=Liu, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184203880215177, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203750191750, language=CN, stringName=杨柳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330184203934741131, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184204022821517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203934741131, language=EN, stringName=Yongai SI, firstName=Yongai, middleName=null, lastName=SI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184204098318990, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203934741131, language=CN, stringName=司咏霭, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330184204182205072, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=gongq@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184204261896850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184204182205072, language=EN, stringName=Qing GONG, firstName=Qing, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184204396114579, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184204182205072, language=CN, stringName=龚青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])], keywords=[Keyword(id=1330184204572275348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, language=CN, orderNo=1, keyword=多晶型药物), Keyword(id=1330184204630995605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, language=CN, orderNo=2, keyword=监管), Keyword(id=1330184204693910166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, language=CN, orderNo=3, keyword=技术要求), Keyword(id=1330184204748436119, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, language=CN, orderNo=4, keyword=表征方法)], refs=[Reference(id=1330184204840710808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=王允雨,杨玉军,杨灿,等.固体药物的多晶型现象及研究进展[J].山东化工,2021,50(3):79-80., articleTitle=null, refAbstract=null), Reference(id=1330184204903625369, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学仿制药晶型研究技术指导原则(试行)[EB/OL].(2021-12-23).[2022-05-01].https://www.cde.org.cn/main/news/viewInfoCommon/0865981f43397249e373ee6d6e5bd66b., articleTitle=null, refAbstract=null), Reference(id=1330184204966539930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=高晶,滕再进,束俭辉,等.固体制剂生产过程中的药物晶型转变[J].中国新药杂志,2018,27(9):1000-1005., articleTitle=null, refAbstract=null), Reference(id=1330184205025260187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=陆成晖,陈智林,孙兴华,等.浅谈新药研发中的晶型研究[J].中国药师,2022,25(7):1245-1248., articleTitle=null, refAbstract=null), Reference(id=1330184205104951964, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. Q6A: Specifications: test procedures and acceptance criteria for new drug substances and new drug products:chemical substances [EB/OL]. (2019-10-06). [2022-05-01]. https://database.ich.org/sites/default/files/Q6A%20Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1330184205167866525, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学药物制剂研究基本技术指导原则[EB/OL].(2005-03-18).[2022-05-01].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=d1eca1ff7bff465d77f8048b8d270b5b., articleTitle=null, refAbstract=null), Reference(id=1330184205234975390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学药物原料药制备和结构确证研究技术指导原则[EB/OL].(2005-03-18).[2022-05-01].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=93b9f98168d771be1cb5b590e1f2e715., articleTitle=null, refAbstract=null), Reference(id=1330184205293695647, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=杨文智,宁黎丽,许真玉.晶型研究在口服固体制剂仿制药药学研发中的几点关注[J].中国药学杂志,2022,57(15):1302-1304., articleTitle=null, refAbstract=null), Reference(id=1330184205436301984, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=RAW A S, FURNESS M S, GILL D S, et al. Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications(ANDAs)[J]. Adv Drug Delivery Rev, 2004, 56: 397-414., articleTitle=null, refAbstract=null), Reference(id=1330184205524382369, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=姚世宁,徐畅,张青青,等.塞来昔布的合成、药理作用和临床应用研究进展[J].中国医药指南,2013,11(28):51-55., articleTitle=null, refAbstract=null), Reference(id=1330184205591491234, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Onsenal® EMEA scientific discussion [EB/OL]. [2022-05-01]. https://www.ema.europa.eu/en/documents/scientific-discussion/onsenal-epar-scientific-discussion_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1330184205654405795, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ZION D B, SHLOMIT W, GENNADY N, et al. Amorphous and crystalline forms of losartan potassium and process for their preparation: EP, 02795637 [P]. 2005-02-09., articleTitle=null, refAbstract=null), Reference(id=1330184205717320356, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=RAMA S, Aurobindo Pharma Ltd., REDDY R V, et al. Process for the crystallization of losartan potassium: EP,1294712A1 [P]. 2003-03-26., articleTitle=null, refAbstract=null), Reference(id=1330184205809595045, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ZION D B, SHLOMIT W, GENNADY N, et al. Amorphous and crystalline forms of losartan potassium and process for their preparation: EP, 02795637 [P]. 2005-02-09., articleTitle=null, refAbstract=null), Reference(id=1330184205880898214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=KUMAR Y, SHARMA T K, BOSE P, et al. Amorphous form of losartan potassium: US, 10532887 [P]. 2006-10-26., articleTitle=null, refAbstract=null), Reference(id=1330184205943812775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=MERCK S, DOHME B V. Public assessment report of the medicines evaluation board in the Netherlands [EB/OL]. [2022-05-01]. https://www.docin.com/p-1446448313.html., articleTitle=null, refAbstract=null), Reference(id=1330184206010921640, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=闫森,张国丽.抗癫痫药布立西坦制剂研究进展[J].广东药科大学学报,2022,38(2):146-150., articleTitle=null, refAbstract=null), Reference(id=1330184206078030505, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Briviact EMEA public assessment report [EB/OL]. [2022-05-01]. https://www.ema.europa.eu/en/documents/assessment-report/briviact-epar-public-assessment-report_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1330184207722197674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=EIICHI Y A, YOSHIHIRO T, DAISUKE A, et al. Discrimination of ranitidine hydrochloride crystals using X-ray micro-computed tomography for the evaluation of three-dimensional spatial distribution in solid dosage forms[J]. Int J Pharm, 2021, 605: 120834., articleTitle=null, refAbstract=null), Reference(id=1330184207793500843, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=BAWAZIR S A, GOUDA M W, EL-SAYED Y M, et al. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers [J]. Int J Pharm, 1998, 36: 270-274., articleTitle=null, refAbstract=null), Reference(id=1330184207852221100, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=ARAVA. Clinical pharmacology/biopharmaceutics review. Application number: NDA 20905 [EB/OL]. [2022-05-01]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020905_S007_ARAVA.pdf., articleTitle=null, refAbstract=null), Reference(id=1330184207923524269, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=WHO. Polymorphism draft chapter for the international pharmacopoeia [EB/OL]. [2022-05-01]. https://digicollections.net/phint/2020/index.html#d/b.10.3.5., articleTitle=null, refAbstract=null), Reference(id=1330184207986438830, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=AGUIAR A J, KRC J J, KINKEL A W, et al. Effect of poly-morphism on the absorption of chloramphenicol from chlor-amphenicol palmitate [J]. J Pharm Sci, 1967, 56(7): 847-853., articleTitle=null, refAbstract=null), Reference(id=1330184208053547695, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. ICH Q8 pharmaceutical development [EB/OL]. (2003-10-08)[2022-05-01]. https://database.ich.org/sites/default/files/Q8%28R2%29%20Concept%20Paper.pdf., articleTitle=null, refAbstract=null), Reference(id=1330184208133239472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. ICH Q9 quality risk management [EB/OL]. (2021-10-26)[2022-05-01]. https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Step_2_Presentation_2021_1126.pdf., articleTitle=null, refAbstract=null), Reference(id=1330184208200348337, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. ICH Q12 technical and regulatory considerations for pharmaceutical product lifecycle management [EB/OL]. (2020-03-30)[2022-05-01]. http://www.cfdi.org.cn/resource/attachment/ueFile/2018/01/TW9uIEphbiAwOCAwOToyNjo1MyAyMDE4NzgzMDc=.pdf., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.05.021, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.05.021, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.05.021, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.05.021, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1683648000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
多晶型药物的监管要求及其药学研究思考
徐晓宏 , 李飞 , 杨柳 , 司咏霭 , 龚青 *
中国医药工业杂志 | 药学管理与信息 2023,54(5): 791-796
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2023 , 54 (5) : 791 -796
多晶型药物的监管要求及其药学研究思考
全屏
[Author(id=1330184203255263868, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184203334955646, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203255263868, language=EN, stringName=Xiaohong XU, firstName=Xiaohong, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184203397870207, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203255263868, language=CN, stringName=徐晓宏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

徐晓宏(1980—),女,工程师,从事化学药物审评研究。

"}, bioImg=null, bioContent=

徐晓宏(1980—),女,工程师,从事化学药物审评研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330184203464979073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184203544670851, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203464979073, language=EN, stringName=Fei LI, firstName=Fei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184203670499972, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203464979073, language=CN, stringName=李飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330184203750191750, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184203817300616, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203750191750, language=EN, stringName=Liu YANG, firstName=Liu, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184203880215177, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203750191750, language=CN, stringName=杨柳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330184203934741131, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184204022821517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203934741131, language=EN, stringName=Yongai SI, firstName=Yongai, middleName=null, lastName=SI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184204098318990, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184203934741131, language=CN, stringName=司咏霭, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1330184204182205072, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=gongq@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184204261896850, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184204182205072, language=EN, stringName=Qing GONG, firstName=Qing, middleName=null, lastName=GONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, NMPA, Bejing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184204396114579, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, authorId=1330184204182205072, language=CN, stringName=龚青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184201514627704, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, xref=null, ext=[AuthorCompanyExt(id=1330184201648845433, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, NMPA, Bejing 100022), AuthorCompanyExt(id=1330184201674011258, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184200168256117, companyId=1330184201514627704, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])]
徐晓宏, 李飞, 杨柳, 司咏霭, 龚青*
作者信息
  • 国家药品监督管理局药品审评中心,北京 100022
通讯作者:
龚青(1983—),男,主任药师,从事化学药物审评研究。E-mail:
作者简介:

徐晓宏(1980—),女,工程师,从事化学药物审评研究。

Opinions on Regulatory Requirements and Pharmaceutical Research of Polymorphic Drugs
Xiaohong XU, Fei LI, Liu YANG, Yongai SI, Qing GONG*
Affiliations
  • Center for Drug Evaluation, NMPA, Bejing 100022
出版时间: 2023-05-10 doi: 10.16522/j.cnki.cjph.2023.05.021
文章导航
收藏切换

药物晶型是影响药物疗效的重要因素,关系到药物的安全性、有效性和质量可控性。近年来,药物晶型研究已成为国内外研究的热点。该研究结合国内外药品监管机构的指导原则、技术要求以及当前国内审评技术要求,分析药物晶型研究的关注点、表征方法及典型案例,旨在为多晶型药物的开发和仿制药注册申报提供参考。

多晶型药物  /  监管  /  技术要求  /  表征方法
徐晓宏, 李飞, 杨柳, 司咏霭, 龚青. 多晶型药物的监管要求及其药学研究思考. 中国医药工业杂志, 2023 , 54 (5) : 791 -796 . DOI: 10.16522/j.cnki.cjph.2023.05.021
Xiaohong XU, Fei LI, Liu YANG, Yongai SI, Qing GONG. Opinions on Regulatory Requirements and Pharmaceutical Research of Polymorphic Drugs[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (5) : 791 -796 . DOI: 10.16522/j.cnki.cjph.2023.05.021

参考文献 引证文献
排序方式:
[1]
王允雨,杨玉军,杨灿,等.固体药物的多晶型现象及研究进展[J].山东化工,2021,50(3):79-80.
[2]
国家药品监督管理局药品审评中心.化学仿制药晶型研究技术指导原则(试行)[EB/OL].(2021-12-23).[2022-05-01].https://www.cde.org.cn/main/news/viewInfoCommon/0865981f43397249e373ee6d6e5bd66b.
[3]
高晶,滕再进,束俭辉,等.固体制剂生产过程中的药物晶型转变[J].中国新药杂志,2018,27(9):1000-1005.
[4]
陆成晖,陈智林,孙兴华,等.浅谈新药研发中的晶型研究[J].中国药师,2022,25(7):1245-1248.
[5]
ICH. Q6A: Specifications: test procedures and acceptance criteria for new drug substances and new drug products:chemical substances [EB/OL]. (2019-10-06). [2022-05-01]. https://database.ich.org/sites/default/files/Q6A%20Guideline.pdf.
[6]
国家药品监督管理局药品审评中心.化学药物制剂研究基本技术指导原则[EB/OL].(2005-03-18).[2022-05-01].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=d1eca1ff7bff465d77f8048b8d270b5b.
[7]
国家药品监督管理局药品审评中心.化学药物原料药制备和结构确证研究技术指导原则[EB/OL].(2005-03-18).[2022-05-01].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=93b9f98168d771be1cb5b590e1f2e715.
[8]
杨文智,宁黎丽,许真玉.晶型研究在口服固体制剂仿制药药学研发中的几点关注[J].中国药学杂志,2022,57(15):1302-1304.
[9]
RAW A S, FURNESS M S, GILL D S, et al. Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications(ANDAs)[J]. Adv Drug Delivery Rev, 2004, 56: 397-414.
[10]
姚世宁,徐畅,张青青,等.塞来昔布的合成、药理作用和临床应用研究进展[J].中国医药指南,2013,11(28):51-55.
[11]
EMA. Onsenal® EMEA scientific discussion [EB/OL]. [2022-05-01]. https://www.ema.europa.eu/en/documents/scientific-discussion/onsenal-epar-scientific-discussion_en.pdf.
[12]
ZION D B, SHLOMIT W, GENNADY N, et al. Amorphous and crystalline forms of losartan potassium and process for their preparation: EP, 02795637 [P]. 2005-02-09.
[13]
RAMA S, Aurobindo Pharma Ltd., REDDY R V, et al. Process for the crystallization of losartan potassium: EP,1294712A1 [P]. 2003-03-26.
[14]
ZION D B, SHLOMIT W, GENNADY N, et al. Amorphous and crystalline forms of losartan potassium and process for their preparation: EP, 02795637 [P]. 2005-02-09.
[15]
KUMAR Y, SHARMA T K, BOSE P, et al. Amorphous form of losartan potassium: US, 10532887 [P]. 2006-10-26.
[16]
MERCK S, DOHME B V. Public assessment report of the medicines evaluation board in the Netherlands [EB/OL]. [2022-05-01]. https://www.docin.com/p-1446448313.html.
[17]
闫森,张国丽.抗癫痫药布立西坦制剂研究进展[J].广东药科大学学报,2022,38(2):146-150.
[18]
EMA. Briviact EMEA public assessment report [EB/OL]. [2022-05-01]. https://www.ema.europa.eu/en/documents/assessment-report/briviact-epar-public-assessment-report_en.pdf.
[19]
EIICHI Y A, YOSHIHIRO T, DAISUKE A, et al. Discrimination of ranitidine hydrochloride crystals using X-ray micro-computed tomography for the evaluation of three-dimensional spatial distribution in solid dosage forms[J]. Int J Pharm, 2021, 605: 120834.
[20]
BAWAZIR S A, GOUDA M W, EL-SAYED Y M, et al. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers [J]. Int J Pharm, 1998, 36: 270-274.
[21]
ARAVA. Clinical pharmacology/biopharmaceutics review. Application number: NDA 20905 [EB/OL]. [2022-05-01]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020905_S007_ARAVA.pdf.
[22]
WHO. Polymorphism draft chapter for the international pharmacopoeia [EB/OL]. [2022-05-01]. https://digicollections.net/phint/2020/index.html#d/b.10.3.5.
[23]
AGUIAR A J, KRC J J, KINKEL A W, et al. Effect of poly-morphism on the absorption of chloramphenicol from chlor-amphenicol palmitate [J]. J Pharm Sci, 1967, 56(7): 847-853.
[24]
ICH. ICH Q8 pharmaceutical development [EB/OL]. (2003-10-08)[2022-05-01]. https://database.ich.org/sites/default/files/Q8%28R2%29%20Concept%20Paper.pdf.
[25]
ICH. ICH Q9 quality risk management [EB/OL]. (2021-10-26)[2022-05-01]. https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Step_2_Presentation_2021_1126.pdf.
[26]
ICH. ICH Q12 technical and regulatory considerations for pharmaceutical product lifecycle management [EB/OL]. (2020-03-30)[2022-05-01]. http://www.cfdi.org.cn/resource/attachment/ueFile/2018/01/TW9uIEphbiAwOCAwOToyNjo1MyAyMDE4NzgzMDc=.pdf.
2023年第54卷第5期
22
4
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.05.021
  • 接收时间:2022-08-09
  • 首发时间:2026-11-19
  • 出版时间:2023-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-08-09
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100022

通讯作者:

龚青(1983—),男,主任药师,从事化学药物审评研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.05.021
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏